Publications (37) María Currás Freixes publications

2023

  1. Genetic bases of pheochromocytoma and paraganglioma

    Journal of Molecular Endocrinology, Vol. 70, Núm. 3

  2. Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility

    Cancers, Vol. 14, Núm. 19

2021

  1. Alterations in slc4a2, slc26a7 and slc26a9 drive acid–base imbalance in gastric neuroendocrine tumors and uncover a novel mechanism for a co-occurring polyautoimmune scenario

    Cells, Vol. 10, Núm. 12

  2. Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma

    Cancers, Vol. 13, Núm. 19

  3. Pheochromocytoma and paraganglioma

    The Hereditary Basis of Childhood Cancer (Springer International Publishing), pp. 101-137

  4. Pheochromocytomas and paragangliomas: An opportunity to apply new advances for optimizing clinical management

    Revista Clinica Espanola

2020

  1. Deficiencias e intoxicaciones vitamínicas

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 14, pp. 793-802

  2. Protocolo diagnóstico y terapéutico de las alteraciones del magnesio y el zinc

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 14, pp. 816-818

  3. SEEN guidelines for the management and prevention of acute adrenal insufficiency

    Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 1, pp. 53-60

2019

  1. Erratum: Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas (The American Journal of Human Genetics (2019) 104(4) (651–664), (S000292971930062X), (10.1016/j.ajhg.2019.02.017))

    American Journal of Human Genetics

  2. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma

    Theranostics, Vol. 9, Núm. 17, pp. 4946-4958

  3. Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 6, pp. 2367-2374

  4. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas

    American Journal of Human Genetics, Vol. 104, Núm. 4, pp. 651-664

2018

  1. Gain-of-function mutations in DNMT3A in patients with paraganglioma

    Genetics in Medicine, Vol. 20, Núm. 12, pp. 1644-1651

  2. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

    Genetics in Medicine, Vol. 20, Núm. 12, pp. 1652-1662

2017

  1. Molecular Genetics of Pheochromocytoma and Paraganglioma

    Contemporary Endocrinology (Humana Press Inc.), pp. 15-45

  2. PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal of Molecular Diagnostics, Vol. 19, Núm. 4, pp. 575-588

  3. Targeted exome sequencing of Krebs cycle genes reveals candidate cancer–predisposing mutations in pheochromocytomas and paragangliomas

    Clinical Cancer Research, Vol. 23, Núm. 20, pp. 6315-6325

  4. Targeted sequencing reveals low-frequency variants in EPHA genes as markers of paclitaxel-induced peripheral neuropathy

    Clinical Cancer Research, Vol. 23, Núm. 5, pp. 1227-1235